80 related articles for article (PubMed ID: 17199177)
1. [Usefulness of the antisense and triplex anti-IGF-1 techniques for postoperative cellular gene therapy of malignant gliomas expressing IGF-1].
Kasprzak HA; Trojan J; Bierwagen M; Kopiński P; Jarocki P; Bartczak K; Czapiewska J
Neurol Neurochir Pol; 2006; 40(6):509-15; discussion 516. PubMed ID: 17199177
[TBL] [Abstract][Full Text] [Related]
2. IGF-I triple helix gene therapy of rat and human gliomas.
Trojan LA; Kopinski P; Mazurek A; Chyczewski L; Ly A; Jarocki P; Nikliński J; Shevelev A; Trzos R; Pan Y; Gitis DJ; Bierwagen M; Czapiewska JL; Wei MX; Michalkiewicz J; Henin D; Popiela T; Evrard F; Kasprzak H; Anthony D; Trojan J
Rocz Akad Med Bialymst; 2003; 48():18-27. PubMed ID: 14737936
[TBL] [Abstract][Full Text] [Related]
3. Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma.
Ly A; Duc HT; Kalamarides M; Trojan LA; Pan Y; Shevelev A; François JC; Noël T; Kane A; Henin D; Anthony DD; Trojan J
Mol Pathol; 2001 Aug; 54(4):230-9. PubMed ID: 11477137
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial.
Westphal M; Ylä-Herttuala S; Martin J; Warnke P; Menei P; Eckland D; Kinley J; Kay R; Ram Z;
Lancet Oncol; 2013 Aug; 14(9):823-33. PubMed ID: 23850491
[TBL] [Abstract][Full Text] [Related]
5. [Treatment modalities for malignant gliomas with reference to their pathophysiology].
Kobayashi S; Takakura K
Gan To Kagaku Ryoho; 1986 Jan; 13(1):11-7. PubMed ID: 3942392
[TBL] [Abstract][Full Text] [Related]
6. [Survival of newly diagnosed malignant glioma patients on combined modality therapy].
Yang QY; Shen D; Sai K; Jiang XB; Ke C; Zhang XH; Mou YG; Chen ZP
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(1):8-10. PubMed ID: 23578444
[TBL] [Abstract][Full Text] [Related]
7. [Combination treatment of malignant brain tumors. Results of initial experiences].
Bauer B; Adrian G
Psychiatr Neurol Med Psychol (Leipz); 1983 Sep; 35(9):566-73. PubMed ID: 6316389
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic factors in malignant gliomas].
Ushio Y; Kochi M
Gan To Kagaku Ryoho; 1996 Apr; 23(5):643-8. PubMed ID: 8678527
[TBL] [Abstract][Full Text] [Related]
9. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
Juratli TA; Schackert G; Krex D
Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
[TBL] [Abstract][Full Text] [Related]
10. IGF-I: from diagnostic to triple-helix gene therapy of solid tumors.
Trojan LA; Kopinski P; Wei MX; Ly A; Glogowska A; Czarny J; Shevelev A; Przewlocki R; Henin D; Trojan J
Acta Biochim Pol; 2002; 49(4):979-90. PubMed ID: 12545204
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic guided laser-induced interstitial thermotherapy (SLITT) in gliomas with intraoperative morphologic monitoring in an open MR: clinical expierence.
Leonardi MA; Lumenta CB
Minim Invasive Neurosurg; 2002 Dec; 45(4):201-7. PubMed ID: 12494354
[TBL] [Abstract][Full Text] [Related]
12. [Surgical treatment combined with radiotherapy and chemotherapy in an unselected population of patients with malignant glioma].
Viñolas N; Arbaiza D; Graus F; Caral L; Ribalta T; Mercader JM; Daniels M; Biete A; Ferrer E; Tolosa E
Med Clin (Barc); 1993 Nov; 101(17):641-3. PubMed ID: 8289507
[TBL] [Abstract][Full Text] [Related]
13. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas.
Lima-Ramos V; Pacheco-Figueiredo L; Costa S; Pardal F; Silva A; Amorim J; Lopes JM; Reis RM
Cancer Genet Cytogenet; 2008 Jan; 180(1):14-9. PubMed ID: 18068527
[TBL] [Abstract][Full Text] [Related]
14. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in high-grade malignant glioma. A multivariate analysis of 76 cases with postoperative radiotherapy.
Würschmidt F; Bünemann H; Heilmann HP
Strahlenther Onkol; 1995 Jun; 171(6):315-21. PubMed ID: 7597616
[TBL] [Abstract][Full Text] [Related]
16. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
17. [Accelerated hyperfractionation in the treatment of malignant glioma].
Sugawara T; Nakazawa M; Mizutani Y; Hyodoh H
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Mar; 54(4):278-85. PubMed ID: 8177703
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor type I biology and targeting in malignant gliomas.
Trojan J; Cloix JF; Ardourel MY; Chatel M; Anthony DD
Neuroscience; 2007 Mar; 145(3):795-811. PubMed ID: 17320297
[TBL] [Abstract][Full Text] [Related]
19. [Effect of the method of treatment on mean survival time of patients with glial brain tumors].
Koziak M; Kuran W; Lipczyńska-Lojkowska W; Wisławski J
Neurol Neurochir Pol; 1986; 20(3):207-13. PubMed ID: 3785551
[TBL] [Abstract][Full Text] [Related]
20. [Malignant brain glioma--a catamnestic study of 100 operated patients].
Victor S; Lausberg G
Zentralbl Neurochir; 1991; 52(2):59-68. PubMed ID: 1659065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
